Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ADMP > SEC Filings for ADMP > Form 8-K on 17-Oct-2013All Recent SEC Filings

Show all filings for ADAMIS PHARMACEUTICALS CORP

Form 8-K for ADAMIS PHARMACEUTICALS CORP


17-Oct-2013

Entry into a Material Definitive Agreement, Change in Directors or Pr


Item 1.01 Entry Into a Material Definitive Agreement.

Pursuant to the provisions of the 2009 Equity Incentive Plan (the "Plan") of Adamis Pharmaceuticals Corporation (the "Company"), effective October 16, 2013, each non-employee director of the Company, Kenneth M. Cohen, Craig A. Johnson, and Tina S. Nova, Ph.D., received a stock option under the Plan to purchase 35,000 shares of common stock. The exercise price for each such option is $0.36 per share, which was the fair market value of the common stock on the date of grant. Each option vests and becomes exercisable over a period of three years from the grant date, at a rate of 1/36 of the option shares each month. Each option is otherwise subject to the provisions of the Plan.



Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

The Information set forth under Item 1.01 above with respect to the awards of options under the Plan is incorporated herein by reference.



Item 5.07 Submission of Matters to a Vote of Security Holders.

The Annual Meeting of Stockholders of the Company was held on October 15, 2013, at the Company's headquarters at 11455 El Camino Real, Suite 310, San Diego, California 92130 at 8:00 a.m. local time. The following proposals were submitted to and approved by the stockholders at the meeting:

1. Election of the five nominees to the board of directors:

                          Votes For        Votes Withheld    Broker Non-Votes
Dennis J. Carlo, Ph.D.     56,074,551          1,552,908         29,952,754
Kenneth M. Cohen           56,221,663          1,405,796         29,952,754
Craig A. Johnson           51,020,127          6,607,332         29,952,754
David J. Marguglio         56,313,288          1,314,171         29,952,754
Tina S. Nova, Ph.D.        56,263,710          1,363,749         29,952,754

2. Approval of a proposal to amend our Amended and Restated Certificate of Incorporation ("Restated Certificate") to effect a reverse stock split of the Company's issued and outstanding common stock, if the board of directors of the Company (the "Board") in its discretion determines to effect a reverse stock split, by a ratio of not less than 1-for-2 and not more than 1-for-25 at any time within 18 months after the date of the annual meeting, with the exact ratio to be set at a whole number within this range as determined by the Board in its sole discretion, with a possible reduction in the number of authorized shares of common stock depending on the exact ratio of the reverse stock split, as described in the definitive proxy statement relating to the annual meeting;

Votes For Votes Against Votes Abstaining Broker Non-Votes 81,939,891 5,439,368 200,954 0

3. Approval, on a nonbinding advisory basis, of the compensation of the Company's named executive officers:

Votes For Votes Against Votes Abstaining Broker Non-Votes 55,252,584 2,176,840 198,035 29,952,754

4. Approval to vote, on an advisory basis, on the frequency of holding an advisory vote on executive compensation:


  Frequency     Votes For  Votes Against   Votes Abstaining

  One Year      52,785,858        0            424,896

  Two Years        730,683        0            424,896

  Three Years    3,686,022        0            424,896

5. Ratification of the selection of Mayer Hoffman McCann PC as independent registered public accounting firm for the year ending March 31, 2014:

Votes For Votes Against Votes Abstaining Broker Non-Votes 81,919,903 1,105,461 4,554,849 0


  Add ADMP to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ADMP - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.